-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Atypical From: Garry E. Siegel, M.D. (garrys@mindspring.com) Wed Mar 28 15:49:54 2007 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Garry E. Siegel, M.D.: "Re: Antibiotic prophylaxis" Previous message: Ronald Ainsworth: "Re: Antibiotic prophylaxis" In reply to: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Atypical" Next in thread: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Atypical" Why not sample first, i.e. H-scope, D and C? Garry At Wed, 28 Mar 2007, Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C. wrote: > >At Wed, 28 Mar 2007, Elrod, Darryl G Maj 48 MDOS/SGOBO wrote: >> >>69 yo G2P2 with postmenopausal bleeding, not entirely known where the >>source was at first. Had a colonoscopy and cystoscopy prior to getting >>to me. >> >>EMB shows atypical glandular proliferation, no hyperplasia seen. >> >>Suggestions for treatment? The patient is not keen on medication or >>further biopsies and wants definitive treatment. >> >>Thanks, >> >>Glen >> >>//SIGNED// >> >>D. Glen Elrod, Maj., USAF, MC >> >>Obstetrician/Gynecologist >> >>Chief of Obstetrics >> >>48 MDOS/SGOBO >> >>RAF Lakenheath, England >> >>Telephone DSN: 314-226-8130 >> >> Comm: +44 (0) 1638 52 8130 >> >>Notice of Confidentiality >>Under the Privacy Act of 1974, you must safeguard all information >>reflected on this e-mail and, if applicable, all attachments. >>Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131, AFI >>37-132, AFI 33-219, and PL 93-579" >>This e-mail message including any attachments is for the sole use of the >>intended recipient(s) and may contain confidential and privileged >>information. Any unauthorized review, use, disclosure or distribution is >>prohibited. If you are not the intended recipient, please contact the >>sender by reply e-mail and destroy all copies of the original message. >>Any questions pertaining to disclosure should be directed to the privacy >>officer. > >Vag hsyt BSO, TAH BSO depending on anatomy etc. 20-50% chance they see >well diff adeno on final pathalogy. > >-- > Take care, John > -- Garry E. Siegel, M.D. Private Practice Roswell, GA Next message: Garry E. Siegel, M.D.: "Re: Antibiotic prophylaxis" Previous message: Ronald Ainsworth: "Re: Antibiotic prophylaxis" In reply to: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Atypical" Next in thread: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Atypical"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Fri May 2 04:47:14 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.